TD Cowen Reiterates Buy Rating on Chimerix (CMRX)

August 14, 2024 11:07 AM EDT Send to a Friend
TD Cowen analyst Joseph Thome reiterated a Buy rating and $8.00 price target on Chimerix (NASDAQ: CMRX).The analyst commented, "Chimerix ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login